Siemens Healthineers AG
XETRA:SHL

Watchlist Manager
Siemens Healthineers AG Logo
Siemens Healthineers AG
XETRA:SHL
Watchlist
Price: 49.8 EUR 1.36% Market Closed
Market Cap: 55.7B EUR
Have any thoughts about
Siemens Healthineers AG?
Write Note

Net Margin
Siemens Healthineers AG

8.4%
Current
9%
Average
2.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
8.4%
=
Net Income
1.9B
/
Revenue
22.1B

Net Margin Across Competitors

Country DE
Market Cap 55.6B EUR
Net Margin
8%
Country US
Market Cap 204.9B USD
Net Margin
14%
Country US
Market Cap 195.2B USD
Net Margin
29%
Country US
Market Cap 146.7B USD
Net Margin
16%
Country US
Market Cap 132.6B USD
Net Margin
11%
Country IE
Market Cap 110.6B USD
Net Margin
12%
Country US
Market Cap 64.7B USD
Net Margin
9%
Country CN
Market Cap 319.2B CNY
Net Margin
34%
Country US
Market Cap 41.6B USD
Net Margin
74%
Country US
Market Cap 37.7B USD
Net Margin
9%
Country US
Market Cap 35.8B USD
Net Margin
23%
No Stocks Found

Siemens Healthineers AG
Glance View

Market Cap
55.6B EUR
Industry
Health Care

Siemens Healthineers AG stands at the forefront of medical technology, championing innovation in healthcare that dramatically enhances patient outcomes around the globe. Established as a subsidiary of the industrial giant Siemens AG, the company has carved out its own identity as a leader in diagnostic imaging, laboratory diagnostics, and digital health services. With a rich history spanning over a century, Siemens Healthineers has continuously evolved, investing heavily in research and development to produce cutting-edge technologies such as advanced imaging equipment like MRI and CT scanners. This relentless pursuit of excellence equips healthcare providers with the tools necessary to deliver accurate diagnoses and efficient patient care, positioning the company as a crucial player in an ever-growing healthcare market. For investors, Siemens Healthineers presents an enticing opportunity, driven by the increasing global demand for medical advancements and the aging population seeking better healthcare solutions. By capitalizing on trends like digitalization and personalized medicine, the company is poised for sustainable growth, offering a robust portfolio of products and services that cater to a diverse range of medical needs. With a strong commitment to expanding its market presence through strategic partnerships and acquisitions, Siemens Healthineers is not just a provider of medical technology; it’s a pivotal force in reshaping the future landscape of healthcare, making it an attractive investment for those looking to support innovation while reaping financial rewards.

SHL Intrinsic Value
73.51 EUR
Undervaluation 32%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
8.4%
=
Net Income
1.9B
/
Revenue
22.1B
What is the Net Margin of Siemens Healthineers AG?

Based on Siemens Healthineers AG's most recent financial statements, the company has Net Margin of 8.4%.